Back to VA VANGUARD CAPITAL MANAGEMENT LLC
XLO2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in XILIO THERAPEUTICS INC
Yes. Vanguard Capital Management holds 178,517 shares of XLO (Xilio Therapeutics), worth $1.7M, as of its Q2 2026 13F filing. It increased the position by 54,857 shares (+44.4%) from Q1 2026. Vanguard Capital Management has held XLO in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$1.7M
Current Shares
178,517
Total Value Change
+$670,212
Total Shares Change
+54,857
Quarter-by-Quarter History
Other major holders of XLO: ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY